657 related articles for article (PubMed ID: 28877379)
1. Short-term safety and efficacy of left atrial appendage closure with the WATCHMAN device in patients with small left atrial appendage ostia.
Venkataraman G; Strickberger SA; Doshi S; Ellis CR; Lakkireddy D; Whalen SP; Cuoco F
J Cardiovasc Electrophysiol; 2018 Jan; 29(1):17-21. PubMed ID: 28877379
[TBL] [Abstract][Full Text] [Related]
2. Usable implantation depth for watchman left atrial appendage occlusion is greater with appendage angiography than transesophageal echocardiography.
Glassy MS; Sharma G; Singh GD; Smith TWR; Fan D; Rogers JH
Catheter Cardiovasc Interv; 2019 Apr; 93(5):E311-E317. PubMed ID: 30311343
[TBL] [Abstract][Full Text] [Related]
3. Left atrial appendage orifice diameter measured with trans-esophageal echocardiography is independently related with peri-device leakage after Watchman device implantation.
Chen YY; Zhang YH; Chen X; Huang WP; Xu B; Su X; Chen YH
Int J Cardiovasc Imaging; 2019 Oct; 35(10):1831-1839. PubMed ID: 31321654
[TBL] [Abstract][Full Text] [Related]
4. Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure.
Saw J; Fahmy P; Azzalini L; Marquis JF; Hibbert B; Morillo C; Carrizo A; Ibrahim R
J Cardiovasc Electrophysiol; 2017 Apr; 28(4):396-401. PubMed ID: 28128883
[TBL] [Abstract][Full Text] [Related]
5. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
[TBL] [Abstract][Full Text] [Related]
6. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
[TBL] [Abstract][Full Text] [Related]
7. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
[TBL] [Abstract][Full Text] [Related]
8. Left atrial appendage closure: First in man with the 4th generation WATCHMAN device.
Ledwoch J; Franke J; Gonzaga M; Bertog S; Braut A; Hofmann I; Vaskelyte L; Gafoor S; Reddy V; Sievert H
Catheter Cardiovasc Interv; 2016 Mar; 87(4):787-94. PubMed ID: 26354821
[TBL] [Abstract][Full Text] [Related]
9. First Experience of Transcatheter Leak Occlusion With Detachable Coils Following Left Atrial Appendage Closure.
Della Rocca DG; Horton RP; Di Biase L; Bassiouny M; Al-Ahmad A; Mohanty S; Gasperetti A; Natale VN; Trivedi C; Gianni C; Burkhardt JD; Gallinghouse GJ; Hranitzky P; Sanchez JE; Natale A
JACC Cardiovasc Interv; 2020 Feb; 13(3):306-319. PubMed ID: 31954677
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
[TBL] [Abstract][Full Text] [Related]
11. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography measurement of the left atrial appendage for optimal sizing of the Watchman device.
Xu B; Betancor J; Sato K; Harb S; Abdur Rehman K; Patel K; Kumar A; Cremer PC; Jaber W; Rodriguez LL; Schoenhagen P; Wazni O
J Cardiovasc Comput Tomogr; 2018; 12(1):50-55. PubMed ID: 29223726
[TBL] [Abstract][Full Text] [Related]
14. Watchman Occlusion in Long-Standing Persistent Atrial Fibrillation: Larger Left Atrial Appendages With Greater Residual Leak.
Glassy MS; Wung W; Westcott S; Smith TWR; Fan D; Rogers JH; Singh GD
JACC Cardiovasc Interv; 2019 Jun; 12(11):1018-1026. PubMed ID: 31171276
[TBL] [Abstract][Full Text] [Related]
15. Cardiac CT and echocardiographic evaluation of peri-device flow after percutaneous left atrial appendage closure using the AMPLATZER cardiac plug device.
Jaguszewski M; Manes C; Puippe G; Salzberg S; Müller M; Falk V; Lüscher T; Luft A; Alkadhi H; Landmesser U
Catheter Cardiovasc Interv; 2015 Feb; 85(2):306-12. PubMed ID: 25205611
[TBL] [Abstract][Full Text] [Related]
16. Delayed endothelialization of watchman device identified with cardiac CT.
Sivasambu B; Arbab-Zadeh A; Hays A; Calkins H; Berger RD
J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1319-1324. PubMed ID: 31257658
[TBL] [Abstract][Full Text] [Related]
17. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
18. Changes in Left Atrial Appendage Dimensions Following Volume Loading During Percutaneous Left Atrial Appendage Closure.
Spencer RJ; DeJong P; Fahmy P; Lempereur M; Tsang MYC; Gin KG; Lee PK; Nair P; Tsang TSM; Jue J; Saw J
JACC Cardiovasc Interv; 2015 Dec; 8(15):1935-1941. PubMed ID: 26738661
[TBL] [Abstract][Full Text] [Related]
19. Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016.
Jazayeri MA; Vuddanda V; Turagam MK; Parikh V; Lavu M; Atkins D; Earnest M; Di Biase L; Natale A; Wilber D; Reddy YM; Lakkireddy DR
J Cardiovasc Electrophysiol; 2018 Jan; 29(1):5-13. PubMed ID: 28988455
[TBL] [Abstract][Full Text] [Related]
20. The value of the left atrial appendage orifice perimeter of 3D model based on 3D TEE data in the choice of device size of LAmbre™ occluder.
Jia D; Zhou Q; Song HN; Zhang L; Chen JL; Liu Y; Kong B; He FZ; Wang YJ; Yang YT
Int J Cardiovasc Imaging; 2019 Oct; 35(10):1841-1851. PubMed ID: 31134413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
